Nobivac® Feline 1-HCPCh+FeLV
Manufacturer: Intervet/Merck Animal Health
This treatment applies to Cats
Feline Leukemia, Rhinotracheitis, Calici, Panleukopenia, Chlamydia Psittaci vaccine
Modified Live Virus and Chlamydia and Killed Virus
For Veterinary Use In Cats Only
In The Absence Of A Veterinarian-client-patient Relationship, U.s. Federal Regulations Prohibit The Relabeling, Repackaging, Resale Or Redistribution Of The Individual Contents Of This Package.
Nobivac® Feline 1-HCPCh + FeLV vaccine is a combination vaccine that unites the benefits of Nobivac® Feline 1-HCPCh and Nobivac® FeLV in one vaccination.
Nobivac® Feline 1-HCPCh vaccine is a modified live virus and chlamydia vaccine for the vaccination of healthy cats as an aid in the prevention of disease caused by feline rhinotracheitis, calici, and panleukopenia viruses and Chlamydia psittaci.
Nobivac® FeLV vaccine is recommended for the vaccination of healthy cats as an aid in the prevention of lymphoid tumors caused by, and diseases associated with, feline leukemia virus (FeLV) infection. Vaccination with this product prevents persistent viremia in cats exposed to virulent feline leukemia virus.
The feline leukemia virus, subgroups A and B, are cultured in tissue culture cells. The virus has been chemically inactivated and combined with a proprietary adjuvant designed to enhance the immune response.
This item is NON-RETURNABLE and NON-REFUNDABLE.
A valid veterinarian prescription is required to purchase this item in the state of Minnesota. Please contact your veterinarian for a prescription.